TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
SDS Life Science AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
7,163
|
7,171
|
6,559 |
| Financial expenses |
60
|
126
|
1 |
| Earnings before taxes |
-305
|
-223
|
244 |
| EBITDA |
-175
|
-98
|
247 |
| Total assets |
2,535
|
2,712
|
3,154 |
| Current assets |
2,150
|
2,375
|
3,134 |
| Current liabilities |
1,159
|
1,197
|
1,352 |
| Equity capital |
241
|
95
|
122 |
| - share capital |
18
|
18
|
20 |
| Employees (average) |
50
|
45
|
34 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
9.5%
|
3.5%
|
3.9% |
| Turnover per employee |
143
|
159
|
193 |
| Profit as a percentage of turnover |
-4.3%
|
-3.1%
|
3.7% |
| Return on assets (ROA) |
-9.7%
|
-3.6%
|
7.8% |
| Current ratio |
185.5%
|
198.4%
|
231.8% |
| Return on equity (ROE) |
-126.6%
|
-234.7%
|
200% |
| Change turnover |
-29
|
1,144
|
725 |
| Change turnover % |
0%
|
19%
|
12% |
| Chg. No. of employees |
5
|
11
|
7 |
| Chg. No. of employees % |
11%
|
32%
|
26% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.